Costimulatory activation of murine invariant natural killer T cells by toll-like receptor agonists

Cellular Immunology

Volumn 277, Issue 1-2, 2012, Pages 33-43

  Kulkarni, Raveendra R ^a,c   Villanueva, Alexander Ian ^a   Elawadli, Inas ^a   Jayanth, Preethi ^a,d   Read, Leah R ^a   Mansour Haeryfar, S M ^b   Sharif, Shayan ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

GalCer; CD1d; CD3 stimulation; Innate immunity; T cell receptors

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; BETA ACTIN; CD3 ANTIBODY; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL MATURATION; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DNA SYNTHESIS; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD3; CELL LINE; CYTOKINES; DENDRITIC CELLS; GALACTOSYLCERAMIDES; GENE EXPRESSION REGULATION; LYMPHOCYTE ACTIVATION; MICE; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; TOLL-LIKE RECEPTORS;

MURINAE;

EID: 84864298403     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.06.002     Document Type: Article

References (42)

1. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Delovitch T.L. Regulation of autoimmune disease by natural killer T cells. J. Mol. Med. 2002, 5:290-300.
2. Wu L., Van Kaer L. Natural killer T cells and autoimmune disease. Curr. Mol. Med. 2009, 1:4-14.
3. Tupin E., Kinjo Y., Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 2007, 6:405-417.
4. Kulkarni R.R., Haeryfar S.M., Sharif S. The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity?. J. Leukoc. Biol. 2010, 4:635-643.
5. Kabelitz D. Expression and function of toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 2007, 1:39-45.
6. Kulkarni R., Behboudi S., Sharif S. Insights into the role of toll-like receptors in modulation of T cell responses. Cell Tissue Res. 2010, 343:141-152.
7. Caron G., Duluc D., Fremaux I., Jeannin P., David C., Gascan H., Delneste Y. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 2005, 3:1551-1557.
8. Cottalorda A., Verschelde C., Marcais A., Tomkowiak M., Musette P., Uematsu S., Akira S., Marvel J., Bonnefoy-Berard N. TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur. J. Immunol. 2006, 7:1684-1693.
9. Gelman A.E., Zhang J., Choi Y., Turka L.A. Toll-like receptor ligands directly promote activated CD4+T cell survival. J. Immunol. 2004, 10:6065-6073.
10. Lee S.M., Joo Y.D., Seo S.K. Expression and function of TLR2 on CD4 versus CD8 T Cells. Immune Netw. 2009, 4:127-132.
11. Marsland B.J., Nembrini C., Grun K., Reissmann R., Kurrer M., Leipner C., Kopf M. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis. J. Immunol. 2007, 6:3466-3473.
12. Simone R., Floriani A., Saverino D., TLR3 Stimulation of Human CD4 T Lymphocytes via TLR5 and TLR7/8 up-regulates expression of costimulatory and modulates proliferation. Open Microbiol. J. 2009, 3:1-8.
13. Tabiasco J., Devevre E., Rufer N., Salaun B., Cerottini J.C., Speiser D., Romero P. Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. J. Immunol. 2006, 12:8708-8713.
14. Tsujimoto H., Ono S., Matsumoto A., Kawabata T., Kinoshita M., Majima T., Hiraki S., Seki S., Moldawer L.L., Mochizuki H. A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells. J. Hepatol. 2006, 6:836-843.
15. Shimizu H., Matsuguchi T., Fukuda Y., Nakano I., Hayakawa T., Takeuchi O., Akira S., Umemura M., Suda T., Yoshikai Y. Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 2002, 4:1265-1277.
16. Gardner T.R., Chen Q., Jin Y., Ajuebor M.N. Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells. Am. J. Pathol. 2010, 4:1779-1789.
17. Askenase P.W., Itakura A., Leite-de-Moraes M.C., Lisbonne M., Roongapinun S., Goldstein D.R., Szczepanik M. TLR-dependent IL-4 production by invariant Valpha14+Jalpha18+ NKT cells to initiate contact sensitivity in vivo. J. Immunol. 2005, 10:6390-6401.
18. Moreno M., Mol B.M., von Mensdorff-Pouilly S., Verheijen R.H., de Jong E.C., von Blomberg B.M., van den Eertwegh A.J., Scheper R.J., Bontkes H.J. Differential indirect activation of human invariant natural killer T cells by toll-like receptor agonists. Immunotherapy 2009, 4:557-570.
19. Nagarajan N.A., Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 2007, 5:2706-2713.
20. Tyznik A.J., Tupin E., Nagarajan N.A., Her M.J., Benedict C.A., Kronenberg M. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 2008, 7:4452-4456.
21. Raftery M.J., Winau F., Giese T., Kaufmann S.H., Schaible U.E., Schonrich G. Viral danger signals control CD1d de novo synthesis and NKT cell activation. Eur. J. Immunol. 2008, 3:668-679.
22. Suzuki Y., Wakita D., Chamoto K., Narita Y., Tsuji T., Takeshima T., Gyobu H., Kawarada Y., Kondo S., Akira S., Katoh H., Ikeda H., Nishimura T. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. Cancer Res. 2004, 23:8754-8760.
23. Lantz O., Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 1994, 3:1097-1106.
24. Stuart J.K., Bisch S.P., Leon-Ponte M., Hayatsu J., Mazzuca D.M., Vareki S.M., Haeryfar S.M. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase. Int. Immunopharmacol. 2010, 9:1068-1076.
25. Gui M., Li J., Wen L.J., Hardy R.R., Hayakawa K. TCR beta chain influences but does not solely control autoreactivity of V alpha 14J281T cells. J. Immunol. 2001, 11:6239-6246.
26. Burdin N., Brossay L., Koezuka Y., Smiley S.T., Grusby M.J., Gui M., Taniguchi M., Hayakawa K., Kronenberg M. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J. Immunol. 1998, 7:3271-3281.
27. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 1997, 6:2723-2730.
28. Cho W.G., Albuquerque R.J., Kleinman M.E., Tarallo V., Greco A., Nozaki M., Green M.G., Baffi J.Z., Ambati B.K., De Falco M., Alexander J.S., Brunetti A., De Falco S., Ambati J. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc. Natl. Acad. Sci. USA 2009, 17:7137-7142.
29. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 9:e45.
30. Parvizi P., Read L.R., Abdul-Careem M.F., Sarson A.J., Lusty C., Lambourne M., Thanthrige-Don N., Burgess S.C., Sharif S. Cytokine gene expression in splenic CD4+ and CD8+ T cell subsets of genetically resistant and susceptible chickens infected with Marek's disease virus. Vet. Immunol. Immunopathol. 2009, 2-4:209-217.
31. Villanueva A.I., Kulkarni R.R., Sharif S. Synthetic double-stranded RNA oligonucleotides are immunostimulatory for chicken spleen cells. Dev. Comput. Immunol. 2011, 1:28-34.
32. Marshall J.D., Fearon K.L., Higgins D., Hessel E.M., Kanzler H., Abbate C., Yee P., Gregorio J., Cruz T.D., Lizcano J.O., Zolotorev A., McClure H.M., Brasky K.M., Murthy K.K., Coffman R.L., Nest G.V. Superior activity of the type C class of ISS in vitro and in vivo across multiple species. DNA Cell Biol. 2005, 2:63-72.
33. He T., Tang C., Xu S., Moyana T., Xiang J. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity. Cell. Mol. Immunol. 2007, 2:105-111.
34. Hiromatsu T., Matsuguchi T., Shimizu H., Yajima T., Nishimura H., Arai T., Nimura Y., Yoshikai Y. NK T cells stimulated with a ligand for TLR2 at least partly contribute to liver injury caused by Escherichia coli infection in mice. Eur. J. Immunol. 2003, 9:2511-2519.
35. Gelman A.E., LaRosa D.F., Zhang J., Walsh P.T., Choi Y., Sunyer J.O., Turka L.A. The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 2006, 5:783-793.
36. McCarron M., Reen D.J. Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation. J. Immunol. 2009, 1:55-62.
37. Davis K.M., Nakamura S., Weiser J.N. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J. Clin. Invest. 2011, 121:3666-3676.
38. van den Heuvel M.J., Garg N., Van Kaer L., Haeryfar S.M. NKT cell costimulation: experimental progress and therapeutic promise. Trends Mol. Med. 2010, 17:65-77.
39. Yamamoto M., Akira S. TIR domain-containing adaptors regulate TLR signaling pathways. Adv. Exp. Med. Biol. 2005, 560:1-9.
40. Hobbs J.A., Cho S., Roberts T.J., Sriram V., Zhang J., Xu M., Brutkiewicz R.R. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J. Virol. 2001, 22:10746-10754.
41. Motsinger A., Haas D.W., Stanic A.K., Van Kaer L., Joyce S., Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 2002, 7:869-879.
42. Funderburg N., Luciano A.A., Jiang W., Rodriguez B., Sieg S.F., Lederman M.M. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 2008, 4:e1915.